Floatz logo

mln9708

Autologous Stem Cell Transplant

TakedaPhase 3Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
81/ 100

Competitive context

12 Active assets in the Autologous Stem Cell Transplant cohort.

Asset / SponsorPhaseRating
Bendamustine
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2B
DEXAMETHASONE
Jacob Laubach, MD
Phase 2CCC
Cytosin-Arabinosid
Masonic Cancer Center, University of Minnesota
Phase 2CCC
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 2CCC
ETOPOSIDE
Masonic Cancer Center, University of Minnesota
Phase 2CCC

View all 13 →

Same molecule, other indications

mln9708 is also rated in:

Multiple MyelomaDormant
BB
Indicative ·
66 / 100
View asset →
AmyloidosisDormant
BB
Indicative ·
64 / 100
View asset →
Higher-risk Myelodysplastic SyndromeDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →